Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 91

1.

RAAS inhibition and the course of Alport syndrome.

Savva I, Pierides A, Deltas C.

Pharmacol Res. 2016 Mar 16;107:205-210. doi: 10.1016/j.phrs.2016.03.017. [Epub ahead of print]

PMID:
26995302
2.

Y-chromosome phylogeographic analysis of the Greek-Cypriot population reveals elements consistent with Neolithic and Bronze Age settlements.

Voskarides K, Mazières S, Hadjipanagi D, Di Cristofaro J, Ignatiou A, Stefanou C, King RJ, Underhill PA, Chiaroni J, Deltas C.

Investig Genet. 2016 Feb 11;7:1. doi: 10.1186/s13323-016-0032-8. eCollection 2016.

3.

Molecular and Clinical Investigation of Cystinuria in the Greek-Cypriot Population.

Athanasiou Y, Voskarides K, Chatzikyriakidou A, Ignatiou A, Demosthenous P, Elia A, Zavros M, Georgiou I, Pierides A, Deltas C.

Genet Test Mol Biomarkers. 2015 Nov;19(11):641-5. doi: 10.1089/gtmb.2015.0144. Epub 2015 Nov 5.

PMID:
26540609
4.

Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.

Deltas C, Savva I, Voskarides K, Papazachariou L, Pierides A.

Nephron. 2015;130(4):271-80. doi: 10.1159/000435789. Epub 2015 Jul 17.

PMID:
26201269
5.

Co-Inheritance of Functional Podocin Variants with Heterozygous Collagen IV Mutations Predisposes to Renal Failure.

Stefanou C, Pieri M, Savva I, Georgiou G, Pierides A, Voskarides K, Deltas C.

Nephron. 2015;130(3):200-12. doi: 10.1159/000432406. Epub 2015 Jun 26.

PMID:
26138234
6.

COL4A3/COL4A4 heterozygous mutations with TBMN presenting as focal segmental glomerulosclerosis.

Deltas C, Pierides A.

Kidney Int. 2015 Apr;87(4):859. doi: 10.1038/ki.2015.38. No abstract available.

PMID:
25826548
7.

Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O.

Kidney Int. 2015 Oct;88(4):676-83. doi: 10.1038/ki.2015.28. Epub 2015 Mar 4.

PMID:
25738250
8.

Haploinsufficiency of the miR-873/miR-876 microRNA cluster is associated with craniofacial abnormalities.

Koufaris C, Papagregoriou G, Kousoulidou L, Moutafi M, Tauber M, Jouret B, Kieffer I, Deltas C, Tanteles GA, Anastasiadou V, Patsalis PC, Sismani C.

Gene. 2015 Apr 25;561(1):95-100. doi: 10.1016/j.gene.2015.02.018. Epub 2015 Feb 11.

PMID:
25680557
9.

Altered metabolic pathways in clear cell renal cell carcinoma: A meta-analysis and validation study focused on the deregulated genes and their associated networks.

Zaravinos A, Pieri M, Mourmouras N, Anastasiadou N, Zouvani I, Delakas D, Deltas C.

Oncoscience. 2014 Jan 3;1(2):117-31. eCollection 2014.

10.

A novel splice-site mutation in ATP6V0A4 gene in two brothers with distal renal tubular acidosis from a consanguineous Tunisian family.

Nagara M, Voskarides K, Elouej S, Zaravinos A, Riahi Z, Papagregoriou G, Kefi R, Boussetta K, Deltas C, Abdelhak S, Tinsa F.

J Genet. 2014 Dec;93(3):859-63. No abstract available.

PMID:
25572248
11.

Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing.

Papazachariou L, Demosthenous P, Pieri M, Papagregoriou G, Savva I, Stavrou C, Zavros M, Athanasiou Y, Ioannou K, Patsias C, Panagides A, Potamitis C, Demetriou K, Prikis M, Hadjigavriel M, Kkolou M, Loukaidou P, Pastelli A, Michael A, Lazarou A, Arsali M, Damianou L, Goutziamani I, Soloukides A, Yioukas L, Elia A, Zouvani I, Polycarpou P, Pierides A, Voskarides K, Deltas C.

PLoS One. 2014 Dec 16;9(12):e115015. doi: 10.1371/journal.pone.0115015. eCollection 2014.

12.

ccRCC is fundamentally a metabolic disorder.

Zaravinos A, Deltas C.

Cell Cycle. 2014;13(16):2481-2. doi: 10.4161/15384101.2014.947225. No abstract available.

13.

Molecular investigation of distal renal tubular acidosis in Tunisia, evidence for founder mutations.

Nagara M, Voskarides K, Nouira S, Ben Halim N, Kefi R, Aloulou H, Romdhane L, Ben Abdallah R, Ben Rhouma F, Aissa K, Boughamoura L, Kammoun T, Azzouz H, Abroug S, Ben Turkia H, Ayadi A, Mrad R, Chabchoub I, Hachicha M, Chemli J, Deltas C, Abdelhak S.

Genet Test Mol Biomarkers. 2014 Nov;18(11):741-8. doi: 10.1089/gtmb.2014.0175. Epub 2014 Oct 6.

14.

Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies.

Gross O, Perin L, Deltas C.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv124-30. doi: 10.1093/ndt/gfu028. Review.

PMID:
25165179
15.

New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney.

Zaravinos A, Lambrou GI, Mourmouras N, Katafygiotis P, Papagregoriou G, Giannikou K, Delakas D, Deltas C.

PLoS One. 2014 Mar 12;9(3):e91646. doi: 10.1371/journal.pone.0091646. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100063.

16.

Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.

Hadjipanagi D, Chrysanthou S, Voskarides K, Deltas C.

BMC Res Notes. 2014 Mar 5;7:123. doi: 10.1186/1756-0500-7-123.

17.

Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.

Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ Jr, Hodanová K, Vylet'al P, Živná M, Hart TC, Hart PS.

Clin J Am Soc Nephrol. 2014 Mar;9(3):527-35. doi: 10.2215/CJN.06380613. Epub 2014 Feb 7.

18.
19.

CNVs-microRNAs interactions demonstrate unique characteristics in the human genome. An interspecies in silico analysis.

Dweep H, Georgiou GD, Gretz N, Deltas C, Voskarides K, Felekkis K.

PLoS One. 2013 Dec 2;8(12):e81204. doi: 10.1371/journal.pone.0081204. eCollection 2013.

20.

Evidence for activation of the unfolded protein response in collagen IV nephropathies.

Pieri M, Stefanou C, Zaravinos A, Erguler K, Stylianou K, Lapathitis G, Karaiskos C, Savva I, Paraskeva R, Dweep H, Sticht C, Anastasiadou N, Zouvani I, Goumenos D, Felekkis K, Saleem M, Voskarides K, Gretz N, Deltas C.

J Am Soc Nephrol. 2014 Feb;25(2):260-75. doi: 10.1681/ASN.2012121217. Epub 2013 Nov 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk